Maso Capital Partners’s Audentes Therapeutics, Inc BOLD Stock Holding History

Maso Capital Partners’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,280	Closed	-$136K	–	29
2019 Q4	$136K	Buy	+2,280	New	+$85.6K	0.04%	18

Maso Capital Partners's BOLD Position: Q1 2020 in Review

Maso Capital Partners sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 2,280 shares — an estimated $136K sold.

Maso Capital Partners first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $136K in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Maso Capital Partners reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Maso Capital Partners sold 2,280 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $136K.
Maso Capital Partners first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
Maso Capital Partners's Audentes Therapeutics, Inc position peaked at $136K in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Maso Capital Partners's 13F filing for Q1 2020, filed 11 May 2020.